Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 112.63bn | 14.43bn | 103.47bn | 96.50bn |
| Cost of revenue | 40.22bn | 39.49bn | 40.40bn | 43.73bn |
| Gross profit | 72.40bn | 65.81bn | 63.06bn | 52.77bn |
| Research and development | 17.72bn | 2.40bn | 16.48bn | 15.04bn |
| Selling, general and administrative | 4.23bn | 4.55bn | 4.90bn | 4.70bn |
| Operating expenses | 36.57bn | 4.96bn | 35.35bn | 33.14bn |
| Operating income | 35.83bn | 4.05bn | 27.71bn | 19.63bn |
| Pre-tax income | 40.83bn | 35.72bn | 34.06bn | 24.25bn |
| Income tax | 6.03bn | 5.46bn | 4.70bn | 5.03bn |
| Net income | 33.76bn | 4.07bn | 29.42bn | 20.34bn |
| Earnings per share | 10.59 | 9.28 | 9.15 | 6.23 |
| Earnings per share, diluted | 10.48 | 9.19 | 9.05 | 6.17 |
| Weighted average shares | 3.19bn | 3.20bn | 3.22bn | 3.26bn |
| Weighted average shares, diluted | 3.22bn | 3.23bn | 3.25bn | 3.30bn |
| Metric | Aug 19, 2026 | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 47.17bn | 51.38bn | 21.43bn | — | — |
| Short-term investments | — | — | 22.80bn | 1.47bn | 4.44bn | — | — |
| Receivables | — | — | 5.34bn | 777m | 6.42bn | — | — |
| Inventory | — | — | 689m | 78m | 695m | — | — |
| Current assets | — | — | 180.62bn | 153.32bn | 142.69bn | — | — |
| Property, plant and equipment | — | — | 8.43bn | 1.17bn | 8.08bn | — | — |
| Total assets | — | — | 221.42bn | 195.99bn | 185.92bn | — | — |
| Current liabilities | — | — | 52.37bn | 49.67bn | 53.84bn | — | — |
| Long-term debt | — | — | — | 428m | 428m | — | — |
| Total liabilities | — | — | 56.31bn | 53.50bn | 57.84bn | — | — |
| Equity | — | — | 160.30bn | 138.69bn | 124.29bn | 108.74bn | 99.28bn |
| Shares outstanding | — | — | 3.19bn | 3.17bn | 3.21bn | — | — |
| Shares issued | — | — | 3.22bn | 3.17bn | 3.21bn | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | 50.74bn | 39.68bn | 35.33bn | 27.71bn |
| Depreciation and amortisation | 2.25bn | 331m | 3.06bn | 2.86bn |
| Share-based compensation | 3.65bn | 3.88bn | 3.24bn | 3.17bn |
| Capital expenditure | 1.07bn | 1.28bn | 2.30bn | 2.10bn |
| Investing cash flow | −33.18bn | 2.45bn | −17.04bn | −7.37bn |
| Dividends paid | 13.83bn | 11.17bn | 8.01bn | 6.72bn |
| Financing cash flow | −20.16bn | −27.34bn | −21.47bn | −10.24bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)